{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:34:42Z","timestamp":1791063282419,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17766-9","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:37:28Z","timestamp":1759844248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuyan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongjun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoren","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuocheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"5","key":"17766_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/WCO.0000000000000740","volume":"32","author":"J Tanboon","year":"2019","unstructured":"Tanboon, J. & Nishino, I. Classification of idiopathic inflammatory myopathies: pathology perspectives. Curr. Opin. Neurol. 32 (5), 704\u2013714. https:\/\/doi.org\/10.1097\/WCO.0000000000000740 (2019).","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"17766_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","volume":"1852","author":"YB Luo","year":"2015","unstructured":"Luo, Y. B. & Mastaglia, F. L. Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochim. Biophys. Acta. 1852 (4), 622\u2013632. https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.034 (2015).","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"17766_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/14397595.2018.1467257","volume":"28","author":"H Sasaki","year":"2018","unstructured":"Sasaki, H. & Kohsaka, H. Current diagnosis and treatment of polymyositis and dermatomyositis. Mod. Rheumatol. 28 (6), 913\u2013921. https:\/\/doi.org\/10.1080\/14397595.2018.1467257 (2018).","journal-title":"Mod. Rheumatol."},{"issue":"5","key":"17766_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"HoogendijkJE et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, naarden, the Netherlands. Neuromuscul. Disord. 14 (5), 337\u2013345. https:\/\/doi.org\/10.1016\/j.nmd.2004.02.006 (2004).","journal-title":"Neuromuscul. Disord"},{"issue":"9","key":"17766_CR5","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine, L. et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 62 (9), 2757\u20132766. https:\/\/doi.org\/10.1002\/art.27572 (2010).","journal-title":"Arthritis Rheum."},{"issue":"3","key":"17766_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen, A. L. et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 63 (3), 713\u2013721. https:\/\/doi.org\/10.1002\/art.30156 (2011).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"17766_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach, Y., Mammen, A. L., Benveniste, O., Stenzel, W. & Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC international workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies zandvoort, the netherlands, 14\u201316 October 2016. Neuromuscul. Disord. 28 (1), 87\u201399. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.016 (2018).","journal-title":"Neuromuscul. Disord"},{"issue":"2","key":"17766_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/08971900211040291","volume":"36","author":"R Barrons","year":"2023","unstructured":"Barrons, R. Statin-Associated autoimmune myopathy: review of the literature. J. Pharm. Pract. 36 (2), 383\u2013393. https:\/\/doi.org\/10.1177\/08971900211040291 (2023).","journal-title":"J. Pharm. Pract."},{"key":"17766_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejim.2022.04.017","volume":"101","author":"D Prieto-Pe\u00f1a","year":"2022","unstructured":"Prieto-Pe\u00f1a, D. et al. Epidemiological and genetic features of anti-3\u2013hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review. Eur. J. Intern. Med. 101, 86\u201392. https:\/\/doi.org\/10.1016\/j.ejim.2022.04.017 (2022).","journal-title":"Eur. J. Intern. Med."},{"issue":"10","key":"17766_CR10","doi-asserted-by":"publisher","first-page":"e0141616","DOI":"10.1371\/journal.pone.0141616","volume":"10","author":"Y Ge","year":"2015","unstructured":"Ge, Y., Lu, X., Peng, Q., Shu, X. & Wang, G. Clinical characteristics of Anti-3-Hydroxy-3-Methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies. PLoS One. 10 (10), e0141616. https:\/\/doi.org\/10.1371\/journal.pone.0141616 (2015). Published 2015 Oct 28.","journal-title":"PLoS One"},{"issue":"4","key":"17766_CR11","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1097\/MD.0000000000000416","volume":"94","author":"Y Watanabe","year":"2015","unstructured":"Watanabe, Y. et al. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Med. (Baltim). 94 (4), e416. https:\/\/doi.org\/10.1097\/MD.0000000000000416 (2015).","journal-title":"Med. (Baltim)."},{"issue":"2","key":"17766_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mus.24541","volume":"52","author":"V Limaye","year":"2015","unstructured":"Limaye, V. et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve. 52 (2), 196\u2013203. https:\/\/doi.org\/10.1002\/mus.24541 (2015).","journal-title":"Muscle Nerve"},{"issue":"5","key":"17766_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/rheumatology\/kew470","volume":"56","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou, E. et al. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatol. (Oxford). 56 (5), 787\u2013794. https:\/\/doi.org\/10.1093\/rheumatology\/kew470 (2017).","journal-title":"Rheumatol. (Oxford)"},{"issue":"47","key":"17766_CR14","doi-asserted-by":"publisher","first-page":"e13236","DOI":"10.1097\/MD.0000000000013236","volume":"97","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled Immunoprecipitation assay in a Chinese patient cohort with myositis. Med. (Baltim). 97 (47), e13236. https:\/\/doi.org\/10.1097\/MD.0000000000013236 (2018).","journal-title":"Med. (Baltim)."},{"key":"17766_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jocn.2018.08.010","volume":"57","author":"Y Jiao","year":"2018","unstructured":"Jiao, Y. et al. Statin-na\u00efve anti-HMGCR antibody-mediated necrotizing myopathy in China. J. Clin. Neurosci. 57, 13\u201319. https:\/\/doi.org\/10.1016\/j.jocn.2018.08.010 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"17766_CR16","doi-asserted-by":"publisher","first-page":"866701","DOI":"10.3389\/fimmu.2022.866701","volume":"13","author":"P Szczesny","year":"2022","unstructured":"Szczesny, P., Barsotti, S., Nennesmo, I., Danielsson, O. & Dastmalchi, M. Screening for Anti-HMGCR antibodies in a large single myositis center reveals infrequent exposure to Statins and diversiform presentation of the disease. Front. Immunol. 13, 866701. https:\/\/doi.org\/10.3389\/fimmu.2022.866701 (2022). Published 2022 May 4.","journal-title":"Front. Immunol."},{"issue":"2","key":"17766_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","volume":"56","author":"WC Liang","year":"2017","unstructured":"Liang, W. C. et al. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies. Rheumatol. (Oxford). 56 (2), 287\u2013293. https:\/\/doi.org\/10.1093\/rheumatology\/kew386 (2017).","journal-title":"Rheumatol. (Oxford)"},{"issue":"1","key":"17766_CR18","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","volume":"6","author":"P Mohassel","year":"2018","unstructured":"Mohassel, P. et al. Anti-HMGCR myopathy May resemble limb-girdle muscular dystrophy. Neurol. Neuroimmunol. Neuroinflamm. 6 (1), e523. https:\/\/doi.org\/10.1212\/NXI.0000000000000523 (2018). Published 2018 Dec 12.","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"3","key":"17766_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"93","author":"Y Allenbach","year":"2014","unstructured":"Allenbach, Y. et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to Statin. Med. (Baltim). 93 (3), 150\u2013157. https:\/\/doi.org\/10.1097\/MD.0000000000000028 (2014).","journal-title":"Med. (Baltim)."},{"issue":"7","key":"17766_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"Kishi, T. et al. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res. (Hoboken). 69 (7), 1088\u20131094. https:\/\/doi.org\/10.1002\/acr.23113 (2017).","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"10","key":"17766_CR21","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s10072-020-04491-6","volume":"41","author":"D Velardo","year":"2020","unstructured":"Velardo, D., Faravelli, I., Cinnante, C., Moggio, M. & Comi, G. P. Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature review. Neurol. Sci. 41 (10), 3009\u20133013. https:\/\/doi.org\/10.1007\/s10072-020-04491-6 (2020).","journal-title":"Neurol. Sci."},{"key":"17766_CR22","doi-asserted-by":"publisher","unstructured":"Tansley, S. L. et al. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients [published correction appears in J Rheumatol. ;44(9):1417]. J Rheumatol. 2017;44(4):488\u2013492. (2017). https:\/\/doi.org\/10.3899\/jrheum.160871","DOI":"10.3899\/jrheum.160871"},{"key":"17766_CR23","doi-asserted-by":"publisher","unstructured":"Lundberg, I. E. et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups [published correction appears in Ann Rheum Dis. ;77(9):e64]. Ann Rheum Dis. 2017;76(12):1955\u20131964. (2018). https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","DOI":"10.1136\/annrheumdis-2017-211468"},{"issue":"4","key":"17766_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider, L. G. et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res. (Hoboken). 62 (4), 465\u2013472. https:\/\/doi.org\/10.1002\/acr.20035 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"19","key":"17766_CR25","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.3390\/diagnostics13193080","volume":"13","author":"A Ghirardello","year":"2023","unstructured":"Ghirardello, A. et al. Detection of myositis autoantibodies by Multi-Analytic immunoassays in a large multicenter cohort of patients with definite idiopathic inflammatory myopathies. Diagnostics (Basel). 13 (19), 3080 (2023). Published 2023 Sep 28.","journal-title":"Diagnostics (Basel)"},{"key":"17766_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/OARRR.S231195","volume":"12","author":"FM Alenzi","year":"2020","unstructured":"Alenzi, F. M. Myositis specific autoantibodies: A clinical perspective. Open. Access. Rheumatol. 12, 9\u201314. https:\/\/doi.org\/10.2147\/OARRR.S231195 (2020). Published 2020 Jan 14.","journal-title":"Open. Access. Rheumatol."},{"issue":"1","key":"17766_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J. & Chan, E. K. A comprehensive overview on Myositis-Specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin. Rev. Allergy Immunol. 52 (1), 1\u201319. https:\/\/doi.org\/10.1007\/s12016-015-8510-y (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"10","key":"17766_CR28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"Watanabe, Y. et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J. Neurol. Neurosurg. Psychiatry. 87 (10), 1038\u20131044. https:\/\/doi.org\/10.1136\/jnnp-2016-313166 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17766-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17766-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17766-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:37:28Z","timestamp":1759844248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17766-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17766"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17766-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involves human participants and the study was approved by the Ethics Committee of Nanfang Hospital, Southern Medical University, Guangzhou 510515, China (No. NFEC-2023-130). The study followed the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for informed consent from the study subjects was waived by the IRB of the Ethics Committee of Nanfang Hospital, Southern Medical University, Guangzhou 510515, China due to the retrospective study design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"34884"}}